Form 4 for DMRA Damora Therapeutics, Inc.
Accepted 2021-12-06 00:00:00 ET · period of report 2021-12-03 · accession 0001209191-21-068027 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-06 | 2021-12-03 | DMRA | Freve Jonathan | CFO | P - Purchase | $2.49 | +4,000 | 12.0K | +50% | +$9,960 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-03 | P | A | 4,000 | $2.49 | 12,000 | D | — | — |